Specifically, we found the hnRNPC that we validated to promote 4 R-Tau expression is also upregulated in PSP at the transcript level, a sporadic 4 R-Tauopathy, which suggests the putative correlation between hnRNPC expression and disease progression of PSP. Here, MAPT is linked to supranuclear palsy, progressive, 1.